Antibiotic R&D is hard. Getting to approval is harder. Surviving the commercialization step today is almost impossible. Government-based funding to fix the broken antibiotic market is essential to stop this march of the lemmings. Private investment will follow a government incentive and amplify its effect.
pull incentives
Will there be pull incentives to support the broken antibiotics market? Where is Biden?
Europe, as opposed to various national authorities, is well poised to provide funds to support the broken antibiotic market. If this ever comes to be, how will products deserving of such support be chosen? Separately, will European regulators continue their slide back to requiring infeasible clinical trials and thereby limiting access to new antibiotics in Europe or will they wake up?